Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › El Paso › NPI 1538522412
Clinic

Tenet Hospitals Limited

Tenet Hospitals Limited was paid $17.15M by Medicaid between Jan 2018 and Dec 2024, across 128 billing codes. Its largest line is 99284, emergency room visit (serious) — 29% of everything it billed.

33Billing provider infoTENET HOSPITALS LIMITED
EL PASO, TX 79911
33aNPI1538522412assigned 03/30/2016
33bProvider typeCritical Access Hospital Clinic/Center
28Total paid$17.15M
24GClaims268,750
24DCodes billed128
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Critical Access Hospital Clinic/Center providers in Texas

Rank by total paid#2 of 11
Median peer was paid$716K
This provider vs. median24×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201830,480$4.26M
201925,607$1.35M
202018,576$875K
202142,785$2.27M
202254,940$3.34M
202352,177$2.83M
2024incomplete44,185$2.22M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 29% 17,440 16,612 $4.98M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 18% 19,148 18,554 $3.09M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 15% 8,744 8,236 $2.61M
80053 Comprehensive metabolic panel 4.2% 21,558 19,739 $718K
74177 Computed tomography, abdomen and pelvis; with contrast material 3.2% 1,677 1,602 $555K
70450 Computed tomography, head or brain; without contrast material 2.9% 2,026 1,943 $494K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.2% 22,275 20,180 $375K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 1.8% 8,833 8,614 $305K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.7% 10,098 9,439 $289K
96361 Intravenous infusion, hydration; each additional hour 1.7% 9,131 8,311 $283K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.6% 6,554 6,077 $266K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.5% 1,795 1,702 $252K
116 more codes
74176 Computed tomography, abdomen and pelvis; without contrast material 1.1% 248 $182K
71046 Radiologic examination, chest; 2 views <1% 2,824 $166K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,784 $162K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 9,278 $159K
71045 Radiologic examination, chest; single view <1% 3,438 $156K
96375 Therapeutic injection; each additional sequential IV push <1% 5,915 $151K
81000 <1% 11,929 $144K
J7030 Infusion, normal saline solution , 1000 cc <1% 9,014 $138K
87631 <1% 1,070 $115K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 4,962 $90K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 752 $88K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,879 $85K
84484 <1% 3,906 $80K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 3,574 $80K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 2,440 $76K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 1,103 $74K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 947 $67K
87088 <1% 9,421 $63K
83690 <1% 4,773 $55K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,168 $49K
81025 <1% 2,147 $40K
84703 <1% 2,585 $38K
80050 General health panel <1% 144 $36K
J3490 Unclassified drugs <1% 2,886 $33K
74018 <1% 456 $33K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 3,895 $30K
J7050 Infusion, normal saline solution, 250 cc <1% 3,224 $28K
94664 <1% 242 $27K
81001 <1% 4,210 $24K
76801 <1% 240 $23K
87070 <1% 1,341 $23K
87430 <1% 1,351 $22K
87077 <1% 1,592 $21K
84443 Thyroid stimulating hormone (TSH) <1% 889 $20K
87186 <1% 1,336 $20K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 148 $19K
85730 <1% 1,952 $19K
80048 Basic metabolic panel (calcium, ionized) <1% 672 $17K
72125 Computed tomography, cervical spine; without contrast material <1% 117 $17K
83880 <1% 867 $16K
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,970 $16K
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,199 $13K
85610 <1% 2,569 $13K
84702 <1% 591 $12K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 515 $12K
72100 <1% 177 $12K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 43 $12K
73610 <1% 108 $11K
73562 <1% 140 $11K
76819 Fetal biophysical profile; without non-stress testing <1% 67 $10K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 211 $9K
76820 <1% 68 $6K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,128 $6K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 424 $6K
73630 <1% 48 $5K
J0690 Injection, cefazolin sodium, 500 mg <1% 319 $5K
83735 <1% 1,100 $5K
85379 <1% 427 $4K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 83 $4K
83605 <1% 382 $4K
80061 Lipid panel <1% 284 $4K
J7060 5% dextrose/water (500 ml = 1 unit) <1% 78 $3K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 777 $3K
82962 <1% 2,132 $3K
84439 <1% 299 $3K
87807 <1% 223 $3K
86900 <1% 489 $3K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 93 $3K
J2704 Injection, propofol, 10 mg <1% 1,092 $3K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 84 $3K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 80 $3K
A9270 Non-covered item or service <1% 1,388 $2K
73030 <1% 27 $2K
86901 <1% 489 $2K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 147 $2K
84100 <1% 610 $2K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 57 $2K
J0500 Injection, dicyclomine hcl, up to 20 mg <1% 138 $1K
A4216 Sterile water, saline and/or dextrose, diluent/flush, 10 ml <1% 3,038 $1K
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 46 $1K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 22 $1K
86140 <1% 140 $1K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 544 $1K
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 386 $1K
83036 Hemoglobin; glycosylated (A1C) <1% 192 $1K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 13 $1K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 377 $1K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 39 $856.28
73110 <1% 20 $829.70
85027 <1% 116 $721.44
J1170 Injection, hydromorphone, up to 4 mg <1% 167 $624.79
87040 <1% 35 $486.81
82728 <1% 39 $452.77
82150 <1% 17 $439.75
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 25 $390.61
85651 <1% 60 $362.25
S0028 Injection, famotidine, 20 mg <1% 157 $331.66
0001A <1% 149 $299.60
83550 <1% 24 $246.37
J0687 Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg <1% 16 $206.99
86850 <1% 26 $206.38
96376 <1% 90 $195.35
83540 <1% 24 $180.11
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 61 $179.84
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 562 $169.18
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 30 $162.96
0012A <1% 331 $123.48
J2060 Injection, lorazepam, 2 mg <1% 13 $103.39
82565 <1% 15 $90.58
J8499 Prescription drug, oral, non chemotherapeutic, nos <1% 1,445 $89.40
0002A <1% 93 $58.06
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 40 $52.38
94760 <1% 47 $28.31
0011A <1% 253 $5.92
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 31 $3.26
97163 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMORALES, ANTHONY (CFO)